Cargando…
A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect
The successful translation of cytotoxic T lymphocyte antigen-4 (CTLA-4) blockade has revolutionized the concept of cancer immunotherapy. Although monoclonal antibody therapeutics remain the mainstream in clinical practice, aptamers are synthetic oligonucleotides that encompass antibody-mimicking fun...
Autores principales: | Huang, Bo-Tsang, Lai, Wei-Yun, Chang, Yi-Chung, Wang, Jen-Wei, Yeh, Shauh-Der, Lin, Emily Pei-Ying, Yang, Pan-Chyr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573796/ https://www.ncbi.nlm.nih.gov/pubmed/28918052 http://dx.doi.org/10.1016/j.omtn.2017.08.006 |
Ejemplares similares
-
A Novel TNF-α-Targeting Aptamer for TNF-α-Mediated Acute Lung Injury and Acute Liver Failure
por: Lai, Wei-Yun, et al.
Publicado: (2019) -
Targeting androgen receptor as a new potential therapeutic approach to battle tobacco carcinogens-induced non-small cell lung cancer
por: Yeh, Shauh-Der, et al.
Publicado: (2012) -
Screening and antitumor effect of an anti-CTLA-4 nanobody
por: Wan, Ruirong, et al.
Publicado: (2018) -
Rapid single cell detection of Staphylococcus aureus by aptamer-conjugated gold nanoparticles
por: Chang, Yi-Chung, et al.
Publicado: (2013) -
Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)